MR编号 | SE/H/1449/001 |
---|
药品名称 | Addaven |
---|
活性成分 | - chromium(III)chloride hexahydrate 5.33 µg
- Copper chloride dihydrate 0.1 mg
- Ferric citrate hexahydrate 0.54 mg
- Manganese chloride tetrahydrate 19.8 µg
- Potassium iodide 16.6 µg
- Sodium fluoride 0.21 mg
- Sodium molybdate 4.85 µg
- Sodium selenite hydrate 17.3 µg
- Zinc chloride 1.05 mg
|
---|
剂型 | Concentrate for solution for infusion |
---|
上市许可持有人 | Fresenius Kabi AB |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Germany (DE)
- Luxembourg (LU)
- Austria (AT)
Addaven Konzentrat zur Herstellung einer Infusionslösung - France (FR)
- Poland (PL)
Supliven - Hungary (HU)
ADDAVEN koncentrátum oldatos infúzióhoz - Bulgaria (BG)
Addaven - Cyprus (CY)
Addamel N New Concentrate for solution for infusion
|
---|
许可日期 | 2015/02/23 |
---|
最近更新日期 | 2025/01/21 |
---|
药物ATC编码 | - B05XA31 electrolytes in combination with other drugs
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|